Portfolio Companies News
May 17, 2018BONESUPPORT creates its own US Comm...
Lund, Sweden, 08.45 CET, 17 May 2018 – BONESUPPORT HOLDING AB (publ) announces today that the current distribution agreement has been terminated and will be replaced by a network of independent distributors and its own commercial organization. This will allow BONESUPPORT to increase its marke... read more
May 16, 2018Onxeo Provides Business Update and ...
Development of lead product candidate, AsiDNA™, for the treatment of advanced solid tumors, progressing according to plan DRIIV phase I clinical trial ongoing Interim results expected in H2 2018 Cash position of €9.2 million at March 31, 2018, sufficient to support Company’s operati... read more
May 16, 2018Wilson Therapeutics AB (Publ) Inter...
JANUARY 1 – MARCH 31, 2018 Net sales amounted to SEK 0.0 M (0.0) Loss for the period was SEK 68.9 M (loss: 31.4) Loss per share, before and after dilution, totaled SEK 2.43 (loss: 1.22) At March 31, cash and cash equivalents amounted to SEK 426.7 M (339.3) SIGNIFICANT EVENTS D... read more
May 15, 2018Nordic Nanovector ASA: Invitation t...
15.05.2018 20:21 Oslo, Norway, 15 May 2018 Nordic Nanovector ASA (OSE: NANO) announces its first quarter 2018 results on Wednesday, 30 May 2018. First Quarter 2018 Results Presentation and Webcast A presentation by Nordic Nanovector’s senior management team will take place at 8... read more
May 15, 2018Altimmune Announces First Quarter 2...
Conference call and webcast scheduled for tomorrow, May 16 at 8:30am ET GAITHERSBURG, Md., May 15, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced financial results for the three months ended March 31, 2018. Recent Corpora... read more
May 02, 2018Q1 2018 General Market Overview
Since the start in 1996, HealthCap funds have invested in 110 portfolio companies.
41 of the portfolio companies have been taken public on nine different markets.
25 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.